REST and glioblastoma: Despite our initial design efforts, T-65 exhibited limited cytotoxicity towards high-REST GBM cells (T98G and A172), and REST protein amount was not significantly changed after T-65 (4 μM, 24 h) treatment (Additional File 1: Fig. S4A-D).